← Open Payments lookup

BRIAN BARASH: Open Payments

NPI 1689663049 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$125,957 in 155 payments from 9 companies in 2025. Trend: 2023 $175,380 · 2024 $155,263 · 2025 $125,957

Speaker / faculty: $73,344Honoraria: $33,300Consulting: $8,858Travel & lodging: $7,404Food & beverage: $3,052
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.25$33,645
ABBVIE INC.33$23,598
Supernus Pharmaceuticals, Inc.35$18,908
Axsome Therapeutics, Inc.20$14,542
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$14,455
Otsuka America Pharmaceutical, Inc.12$8,914
Alkermes, Inc.6$8,280
Tris Pharma Inc3$3,543
Brainsway USA INC1$71

Products named: UZEDY, VRAYLAR, Qelbree, Auvelity, CAPLYTA, REXULTI, LYBALVI, AUSTEDO XR.

Industry payments across MO — which companies pay providers there.